|
|
|
|
 |
| |
 |
|
About Cancer Care
Northwest's Clinical Research Platform
Today, cancer research is no longer conducted
exclusively at large university cancer centers or major
metropolitan hospitals. Practices like ours are also
making significant contributions.
There are currently 6,500 patients placed in over 100
cancer research studies in the U.S. Oncology research
network. These studies are being conducted on behalf of
more than 50 pharmaceutical and biotechnology companies.
Before a new research study is considered by your
physician, it undergoes extensive evaluation to
determine its benefits to patients. This evaluation
helps assure that the medical science is promising and
safe, and that it fulfills the highest standards of
quality. As a result, your physician is able to offer
the most advanced developments in cancer research and
medicine right here at home.
Research at Cancer Care Northwest
The physicians and staff at Cancer Care Northwest are
committed to clinical research because it allows us to
provide cutting-edge treatment options to our patients,
eliminating the need for them to travel to Seattle for
access to these new and exciting developments.
Additionally, clinical trials play a key role in the
long-term challenge to conquer cancer. Without these
trials, many of the treatment advances and cures we see
today would never have happened.
The Research Department of Cancer Care Northwest
consists of physicians, nurses, and cancer information
specialists working hard to improve the prevention and
treatment of cancer. Through our affiliations with
national and regional clinical research groups, such as
the Southwest Oncology Group, the National Cancer
Institute, the National Surgical Adjuvant Breast and
Bowel Project, and the Puget Sound Oncology Consortium,
we are able to access approximately 100 research trials.
Cancer Care Northwest is one of very few designated
sites for performance of Phase II trials—cutting edge
trials usually found only in academic settings that
investigate such novel treatments as gene therapy and
immunotherapy. We also believe that cancer prevention is
critical, and as such we are actively participating in
several major cancer prevention studies.
Studies are currently available for the following areas:
brain, breast, lung, colon, rectal, liver, prostate,
multiple myeloma, bladder, ovarian, sarcoma, lymphoma,
leukemia, and melanoma.
For more information about these studies or our research
program, please call 228.1000 and ask to speak to
someone in the Research Department.
|
|
|
